News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,053 Results
Type
Article (39696)
Company Profile (311)
Press Release (653046)
Section
Business (204913)
Career Advice (2013)
Deals (35506)
Drug Delivery (91)
Drug Development (81084)
Employer Resources (168)
FDA (16143)
Job Trends (14875)
News (346057)
Policy (32568)
Tag
Academia (2550)
Alliances (49619)
Alzheimer's disease (1296)
Approvals (16107)
Artificial intelligence (164)
Bankruptcy (356)
Best Places to Work (11629)
Biotechnology (217)
Breast cancer (205)
Cancer (1541)
Cardiovascular disease (121)
Career advice (1678)
CAR-T (107)
Cell therapy (316)
Clinical research (65081)
Collaboration (585)
Compensation (311)
COVID-19 (2566)
C-suite (135)
Data (1486)
Diabetes (191)
Diagnostics (6226)
Earnings (85177)
Employer resources (146)
Events (110898)
Executive appointments (493)
FDA (16921)
Funding (524)
Gene therapy (216)
GLP-1 (626)
Government (4353)
Healthcare (18763)
Infectious disease (2663)
Inflammatory bowel disease (118)
Interviews (309)
IPO (16428)
Job creations (3661)
Job search strategy (1431)
Layoffs (430)
Legal (7905)
Lung cancer (228)
Manufacturing (217)
Medical device (13246)
Medtech (13251)
Mergers & acquisitions (19340)
Metabolic disorders (497)
Neuroscience (1663)
NextGen: Class of 2025 (6545)
Non-profit (4485)
Northern California (1881)
Obesity (281)
Opinion (190)
Patents (133)
People (57000)
Phase I (20278)
Phase II (28669)
Phase III (21341)
Pipeline (617)
Postmarket research (2563)
Preclinical (8586)
Radiopharmaceuticals (239)
Rare diseases (290)
Real estate (5942)
Regulatory (21861)
Research institute (2322)
Resumes & cover letters (350)
Southern California (1631)
Startups (3621)
United States (16769)
Vaccines (581)
Weight loss (195)
Date
Today (124)
Last 7 days (433)
Last 30 days (1975)
Last 365 days (34946)
2025 (1866)
2024 (35375)
2023 (40181)
2022 (51293)
2021 (55842)
2020 (54160)
2019 (46664)
2018 (35138)
2017 (32231)
2016 (31638)
2015 (37724)
2014 (31462)
2013 (26510)
2012 (28787)
2011 (29434)
2010 (27528)
Location
Africa (717)
Arizona (203)
Asia (37622)
Australia (6159)
California (4291)
Canada (1562)
China (366)
Colorado (194)
Connecticut (206)
Europe (80636)
Florida (609)
Georgia (148)
Illinois (418)
Indiana (244)
Maryland (687)
Massachusetts (3304)
Michigan (183)
Minnesota (317)
New Jersey (1195)
New York (1211)
North Carolina (791)
Northern California (1881)
Ohio (157)
Pennsylvania (1004)
South America (1097)
Southern California (1631)
Texas (625)
Utah (122)
Washington State (429)
693,053 Results for "decipher biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Veracyte, Inc today announced that nine abstracts focused on its Decipher Prostate and Decipher Bladder Genomic Classifiers will be presented at AUA 2024, the annual meeting of the American Urological Association, taking place May 3-6 in San Antonio.
April 16, 2024
·
7 min read
Drug Development
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
Natera, Inc., a global leader in cell-free DNA and genetic testing, announced a new gastroesophageal cancer trial, DECIPHER, that will utilize the company’s personalized and tumor-informed molecular residual disease test, Signatera™, to guide patient selection and assess the rate of MRD clearance in patients being treated for gastroesophageal cancer.
June 27, 2024
·
5 min read
Biotech Bay
14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding
Veracyte, Inc., a leading cancer diagnostics company, announced that data from 14 presentations at AUA 2024, the annual meeting of the American Urological Association, show that the Decipher Prostate and Decipher Bladder Genomic Classifiers provide better prognostic information for patients with prostate and bladder cancer, compared to standard approaches.
May 6, 2024
·
9 min read
Press Releases
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference
January 14, 2025
·
1 min read
Press Releases
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
January 6, 2025
·
5 min read
Press Releases
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
January 10, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 24, 2024
·
5 min read
Press Releases
Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines
December 6, 2024
·
4 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Press Releases
Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025
January 14, 2025
·
4 min read
1 of 69,306
Next